US: CHME - China Medicine Corporation

Rentabilität für sechs Monate: 0%
Dividendenrendite: 0.00%

Aktionsplan China Medicine Corporation


Über das Unternehmen China Medicine Corporation

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.

weitere details
; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.cmc621.com/cmc/index.php
Цена ао 0.0001
Preisänderung pro Tag: 0% (0.0001)
Preisänderung pro Woche: 0% (0.0001)
Preisänderung pro Monat: 0% (0.0001)
Preisänderung über 3 Monate: -96.67% (0.003)
Preisänderung über sechs Monate: 0% (0.0001)
Preisänderung pro Jahr: 0% (0.0001)
Preisänderung über 3 Jahre: -50% (0.0002)
Preisänderung über 5 Jahre: -99.9% (0.098)
Preisänderung seit Jahresbeginn: -96.67% (0.003)

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 1.43

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 522.59 10
Rentabilität Ebitda, % -63462.78 0
Rentabilität EPS, % -122.79 0
Gesamt: 2

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Senshan Yang Chairman, CEO & Chairman of Guangzhou Konzern Medicine Co., Ltd 1961 (64 Jahr)
Mr. Ho Chi Fung Chief Financial Officer 1972 (53 Jahr)
Ms. Huizhen Yu Controller 1980 (45 Jahre)

Adresse: China, Guangzhou, 2/F Guangri Tower - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.cmc621.com/cmc/index.php